Price target upside
Recursion Pharmaceuticals, Inc. - Class A Common Stock Price Target Upside or Downside
RXRX price target upside based on the current price and analyst average.
Direct answer
Recursion Pharmaceuticals, Inc. - Class A Common Stock's analyst target implies +120.4%.
The average target is $7.25 compared with a recorded current price of $3.29.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Recursion Pharmaceuticals, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.29
- Average price target
- $7.25
- High price target
- $10.00
- Low price target
- $4.00
- Target upside
- +120.4%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026